Dr Mellor, Malaysia, explains why and how he is using immmunoscore in Stage III colon cancer patients

Professor Yoshino, KOL in Asia region, talk about Immunoscore

Dr Tony Dhillon (UK) presenting Immunoscore at the Digestive Cancers Europe Scientific Update: Role of the Immune Response in Early Stage Colorectal Cancers

Testimonial: Dr Su Pin Choo (Curie Oncology, Singapore) on the utility of Immunoscore in early stage Colon Cancer

Managing colorectal cancer patients in the COVID-19 era with Drs Benjamin Weinberg (USA), Matías Chacón and Juan Manuel O’Connor (both Argentina)

Visit Oncology Central here.

2’ to learn more Series: Jacques Fieschi PhD, VP, R&D, presents the R&D department and its technologies, with a focus on Brightplex®

Immunoscore® highlights at ESMO GI. Presentations of Dr Le Bagousse and Jérôme Galon, PhD

Register here to watch the recording now  

Testimonial: Dr Juan Manuel O’Connor (Instituto Alexander Fleming in Buenos Aires, Argentina) on the use of Immunoscore in routine practice in managing early Colon Cancer

Webinar: Evaluating Biomarkers During Clinical Trials for Immunotherapies. A Case Study on the Pioneer Project

The replay of this webinar is available on Xtalks. Please register here

2’ to learn more Series: HalioDx presentation and the company's activities during COVID 19 Pandemic | Vincent Fert, President & CEO

HalioDx presentation and the company's activities during COVID 19 Pandemic

2’ to learn more Series: Who are HalioDx solutions designed for? | Vincent Fert, President & CEO

2’ to learn more Series

Franck Pagès, MD, PhD, on Selecting Patients With Advanced Colon Cancer for Treatment

Visit JNCCN 360 Colorectal Cancer here.

Webinar: Capturing the Complexity of the Tumor Microenvironment | Jérôme Galon, PhD & Jacques Fieschi, PhD

The replay of this webinar is available on Xtalks. Please register here

Immunoscore® Colon Symposium - June 1, 2018, Chicago | Jérôme Galon, PhD

Jérôme Galon, PhD, presenting the international validation of Immunoscore® Colon for the classification of colon cancer

Immunoscore® Colon Symposium - June 1, 2018, Chicago | Stanley Hamilton, MD

Stanley Hamilton, MD, opening the symposium dedicated to Immunoscore® Colon clinical utility and its role in early stage colon cancer patients’ management.

Immunoscore® Colon Symposium - June 1, 2018, Chicago | Discussion on clinical cases

Discussion on clinical cases with David Malka, MD, PhD & Marc Van Den Eynde, MD, PhD

Jérôme Galon, winner for the European Inventor Award 2019 for Immunoscore®
Discover HalioDx - Reportage by Grand Luminy Technopole - April 2017
Webinar Biomarker Evaluation for CAR T-Cell Therapy: Impact on Drug Development

The replay of this webinar is available here.

Webinar on Brightplex®: Combining the power of multiplexing & the ease of chromogenic IHC to assess complex immune phenotype

The replay of this webinar is available here.

Immunogram Clinical Seminar (Atlanta, April 2019) | Jérôme Galon, PhD

Approaches to treat immune hot, altered and cold tumors by Jérôme Galon, Research Director Inserm, Paris

Immunogram Clinical Seminar (Atlanta, April 2019) | Jacques Fieschi, PhD

Immunogram proof of concept on CRC samples by Jacques Fieschi, VP R&D HalioDx

HalioDX is part of the COLOSSUS project by performing Immunoscore and help stratification of difficult to treat mCRC patients with a final objective to Improve their management and treatment
Discover how Immunoscore® is predicting the risk of relapse in localized colon cancer in a short video
Dr Jerome Galon on the Prognostic Value of Immunoscore, Onclive - ASCO 2016
Webinar on “Clinical utility of Immunoscore® in colon cancer” with Marc Van Den Eynde, MD, PhD | October 17, 2017
Dr. Fakih Discusses the Utility of Immunoscore® in CRC

Extract of an interview by Cancer.fr of Professor Thierry André, on Immunoscore® in the IDEA France study (in French)

Webinar Immunoscore®: IDEA France study results in Stage III Colon Cancer - Sept. 19, 2019 | Franck Pagès, Eric Van Cutsem
Immunoscore® Webinar New data in Stage II Colon Cancer - March 21, 2019 | Jêrome Galon, PhD